ArticleHealth services research2025
A model to increase care delivery in nursing homes: The role of Institutional Special Needs Plans.
Article in Health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Institutional Special Needs Plans and End-of-Life Outcomes for Nursing Home Residents With Dementia.JAMA health forum · 2026Article
- Medicare Advantage Enrollment in Nursing Homes: 2010-2023.Journal of the American Geriatrics Society · 2026Article
- The Utilization, Application, and Impact of Institutional Special Needs Plans (I-SNPs) in Nursing Facilities: A Rapid Review.Healthcare (Basel, Switzerland) · 2025Review
- Disenrollment From Special Needs and Other Medicare Advantage Plans Among Nursing Home Residents.JAMA network open · 2025Article
- A model to increase care delivery in nursing homes: The role of Institutional Special Needs Plans.Health services research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectiveTo estimate differences in facility-level outcomes between nursing homes which reached Institutional Special Needs Plan (I-SNP) maturity and those which never cared for I-SNP enrollees. STUDY SETTING AND
designWe used a difference-in-differences design to estimate the effect of I-SNP maturity, defined as having at least 33.75% of Medicare long-stayers in the nursing home enrolled in any I-SNP. Our main outcome was the hospitalization rate in each nursing home-year. Secondary outcomes included the share of residents with medication use, fall, urinary tract infection, catheter insertion, pressure ulcer, physical restraint use, increased need for help with activities of daily living (ADLs), and mortality. DATA SOURCES AND ANALYTIC SAMPLE: This repeated cross-sectional study used 100% Medicare claims, Minimum Data Set assessments, and publicly available Medicare Advantage (MA) plan characteristics data (2004-2021). We included all MA beneficiaries who resided in US nursing homes which reached I-SNP maturity and those without I-SNP enrollees. PRINCIPAL
findingsWe identified 2530 nursing homes which reached I-SNP maturity (treated) and 9830 nursing homes without I-SNP enrollees (untreated). There were some differences observed between these nursing homes, including shares of residents who were White (76.42% vs. 84.84%) and on Medicaid (66.94% vs. 55.45%). These nursing homes were also larger on average (141.76 beds vs. 87.56 beds). From the difference-in-differences model, nursing homes which reached I-SNP maturity experienced declines of 4.1 percentage points (pp) for hospitalizations, 1.0 pp for pressure ulcers, 1.3 pp for urinary tract infections (p < 0.001) alongside increases in the need for help with ADLs, use of antipsychotics, falls, and physical restraints.
conclusionsNursing homes which reached I-SNP maturity experienced fewer hospitalizations and pressure ulcers but a decline in function and increase in other negative outcomes. I-SNPs may be a promising model to improve care for long-stay residents, but more research is needed to understand potential adverse consequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.